CliniGA CRO

CliniGA CRO Blog

Reconciling trial insurance with the Türkiye study plan

Review insurance identity, participant allocation, site changes and policy continuity against the actual clinical trial plan.

Cover image for: Reconciling trial insurance with the Türkiye study plan
Photo: National Center for Advancing Translational Sciences from Bethesda, MD; Daniel Soñé Photography, LLC · License: CC BY 2.0 · Cropped and resized.
Published
Updated
Sources checked

An insurance certificate can be current yet inconsistent with the study it is meant to cover. Review the policy against operational changes rather than checking only its expiry date in the start-up tracker.

Read scope before dates

TİTCK provides specific clinical trial insurance guidance. Use that document and current application requirements to assess the study's policy. Avoid deriving a universal coverage duration from a different product or population; the relevant study characteristics and the actual policy wording must be examined together.

Create a coverage reconciliation

Our recommended reconciliation joins protocol identity, sponsor, insured study activities, participant numbers, territory and coverage period. If the certificate names sites or investigators, assess each corresponding change. Record ambiguous wording as an open question for the insurer rather than translating it into an unsupported assurance in the regulatory cover letter.

Check change triggers

  • Match protocol code, title and sponsor across the policy and study records.
  • Review enrollment assumptions and planned procedures against the stated coverage scope.
  • Check amendments, added sites and investigator changes for policy implications.
  • Obtain documented clarification and maintain continuity before the existing coverage ends.

Resolve wording with the insurer

Keep the insurer's explanation with the reviewed policy version and the applicable submission record. A sponsor's interpretation alone cannot repair an unclear exclusion. During study extension, coordinate coverage, participant follow-up and regulatory changes as linked workstreams with separate owners.

Frequently asked questions

Is the certificate expiry date the only critical field?
No. Identity, scope, exclusions and the population covered may be equally consequential.
Does adding a site always require the same policy action?
Check whether the policy identifies sites and assess current guidance and the insurer's documented position.

Sources

  1. TİTCK — Clinical trial insurance guidance
  2. TİTCK — Clinical research application guidance and module notes